Inactive Instrument

News X T L Biopharmaceuticals Ltd Deutsche Boerse AG

Equities

US98386D2080

End-of-day quote Deutsche Boerse AG Other stock markets
- ^EUR	-

05/06	XTL Biopharmaceuticals Signs Deal to Acquire The Social Proxy	MT
05/06	XTL Biopharmaceuticals Ltd. announced that it has received $1.5 million in funding	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

XTL Biopharmaceuticals : Immediate Report of Meeting	13/06	PU
XTL Biopharmaceuticals : NOTICE OF ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 22, 2024 Form 6 K	13/06	PU
XTL Biopharmaceuticals Signs Deal to Acquire The Social Proxy	05/06	MT
XTL Biopharmaceuticals Ltd. announced that it has received $1.5 million in funding	05/06	CI
XTL Biopharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05	CI
XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/05	CI
Top Premarket Gainers	29/04	MT
XTL Biopharmaceuticals : Report Of Foreign Private Issuer - Form 6-K	03/04	PU
XTL Biopharmaceuticals : Immediate Report of Meeting	22/03	PU
XTL Biopharmaceuticals : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON APRIL 30, 2024 - Form 6-K	22/03	PU
Top Midday Gainers	20/03	MT
XTL Biopharmaceuticals to Acquire The Social Proxy; Shares Soar	20/03	MT
XTL To Aquire The Social Proxy	20/03	AQ
XTL Biopharmaceuticals Ltd. announced that it expects to receive $1.5 million in funding	20/03	CI
XTL Biopharmaceuticals Ltd. entered into a binding term sheet to acquire THE SOCIAL PROXY Ltd.	20/03	CI
XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	15/11	CI
XTL Biopharmaceuticals : Report Of Foreign Private Issuer - Form 6-K	15/11	PU
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	21/23/21	AQ
XTL Biopharmaceuticals : OPERATING AND FINANCIAL REVIEW AND PROSPECTS (Form 6-K)	25/21/25	PU
XTL Biopharmaceuticals Ltd. Elects Alexander Rabinovitch as Directors	03/17/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News X T L Biopharmaceuticals Ltd Deutsche Boerse AG

Equities

US98386D2080

Summary

Filters